Scott David Priebe

Array ( [id] => 6668312 [patent_doc_number] => 20030113295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders' [patent_app_type] => new [patent_app_number] => 10/314033 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 21568 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113295.pdf [firstpage_image] =>[orig_patent_app_number] => 10314033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642171 [patent_doc_number] => 20030103942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders' [patent_app_type] => new [patent_app_number] => 10/313852 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 21561 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103942.pdf [firstpage_image] =>[orig_patent_app_number] => 10313852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801622 [patent_doc_number] => 20030096787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Defective adenovirus vectors and use thereof in gene therapy' [patent_app_type] => new [patent_app_number] => 10/301085 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8989 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096787.pdf [firstpage_image] =>[orig_patent_app_number] => 10301085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 452775 [patent_doc_number] => 07247472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-24 [patent_title] => 'Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use' [patent_app_type] => utility [patent_app_number] => 10/494364 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26121 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247472.pdf [firstpage_image] =>[orig_patent_app_number] => 10494364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122433 [patent_doc_number] => 20050014262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor' [patent_app_type] => utility [patent_app_number] => 10/496799 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13853 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014262.pdf [firstpage_image] =>[orig_patent_app_number] => 10496799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 435633 [patent_doc_number] => 07261887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Leishmania as carriers for the delivery of proteins and peptides' [patent_app_type] => utility [patent_app_number] => 10/293867 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8010 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/261/07261887.pdf [firstpage_image] =>[orig_patent_app_number] => 10293867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813218 [patent_doc_number] => 20030072768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Method to enhance an immune response of nucleic acid vaccination' [patent_app_type] => new [patent_app_number] => 10/292136 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8807 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20030072768.pdf [firstpage_image] =>[orig_patent_app_number] => 10292136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6771436 [patent_doc_number] => 20030217376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Insecticide targets and methods of use' [patent_app_type] => new [patent_app_number] => 10/149165 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21729 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20030217376.pdf [firstpage_image] =>[orig_patent_app_number] => 10149165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869457 [patent_doc_number] => 20030082146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Adenovirus vectors with knobless fibers, and their uses' [patent_app_type] => new [patent_app_number] => 10/282121 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14094 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082146.pdf [firstpage_image] =>[orig_patent_app_number] => 10282121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6789123 [patent_doc_number] => 20030140362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'In vivo models for screening inhibitors of hepatitis B virus' [patent_app_type] => new [patent_app_number] => 10/279401 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30132 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20030140362.pdf [firstpage_image] =>[orig_patent_app_number] => 10279401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642162 [patent_doc_number] => 20030103941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Materials and methods for preventing or reducing scar formation' [patent_app_type] => new [patent_app_number] => 10/267488 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13867 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103941.pdf [firstpage_image] =>[orig_patent_app_number] => 10267488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683911 [patent_doc_number] => 20030119775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Respiration uncoupling protein' [patent_app_type] => new [patent_app_number] => 10/265689 [patent_app_country] => US [patent_app_date] => 2002-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 12455 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119775.pdf [firstpage_image] =>[orig_patent_app_number] => 10265689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 518076 [patent_doc_number] => 07193126 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-20 [patent_title] => 'Method for generating overexpression of alleles in genes of unknown function' [patent_app_type] => utility [patent_app_number] => 10/263367 [patent_app_country] => US [patent_app_date] => 2002-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 14118 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/193/07193126.pdf [firstpage_image] =>[orig_patent_app_number] => 10263367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740770 [patent_doc_number] => 20030158139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Decreasing adipose mass by altering RSK2 activity' [patent_app_type] => new [patent_app_number] => 10/261092 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10484 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158139.pdf [firstpage_image] =>[orig_patent_app_number] => 10261092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6647133 [patent_doc_number] => 20030104444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Circular DNA expression cassettes for gene transfer' [patent_app_type] => new [patent_app_number] => 10/252384 [patent_app_country] => US [patent_app_date] => 2002-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14502 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104444.pdf [firstpage_image] =>[orig_patent_app_number] => 10252384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351569 [patent_doc_number] => 20040048261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Invertebrate choline transporter nucleic acids, polypeptides and uses thereof' [patent_app_type] => new [patent_app_number] => 10/241784 [patent_app_country] => US [patent_app_date] => 2002-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20207 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048261.pdf [firstpage_image] =>[orig_patent_app_number] => 10241784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765714 [patent_doc_number] => 20030100114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Methods for regulating T cell subsets by modulating transcription factor activity' [patent_app_type] => new [patent_app_number] => 10/236629 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 34129 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100114.pdf [firstpage_image] =>[orig_patent_app_number] => 10236629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6682692 [patent_doc_number] => 20030118556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Targeted retrograde gene delivery to motor neurons' [patent_app_type] => new [patent_app_number] => 10/237567 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12174 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118556.pdf [firstpage_image] =>[orig_patent_app_number] => 10237567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6724598 [patent_doc_number] => 20030206910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Poloxamer and poloxamine compositions for nucleic acid delivery' [patent_app_type] => new [patent_app_number] => 10/234405 [patent_app_country] => US [patent_app_date] => 2002-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19138 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20030206910.pdf [firstpage_image] =>[orig_patent_app_number] => 10234405 [rel_patent_id] =>[rel_patent_doc_number] =>)